The agency declined to quickly release documents that would identify drugs made at some of the most troubled foreign ...

The Food and Drug Administration says it will begin offering faster reviews to new medicines that align with Trump ...

FDA Commissioner Marty Makary faces declining staff morale as he remakes the agency.

Leaders of the FDA have published a list of new priorities for the agency. They want to deliver rapidly-approved cures and ...

The US Food and Drug Administration announced a new national priority voucher plan that aims to cut drug review times to one ...

HHS secretary Robert F. Kennedy Jr. declared that the FDA’s “suppression of psychedelics” was about to end. Now he and his ...

The FDA is launching a program to reward companies with accelerated drug review and speedy agency feedback, if their actions ...

General Mills has announced it will remove artificial colors from all of its U.S. cereals by next year, and all of its ...

Nuvation Bio Inc. (NYSE: NUVB), a global oncology company focused on tackling some of the toughest challenges in cancer ...

The FDA plans to "unleash AI" on new drug evaluations in order to "radically increase efficiency in the review process." ...

The Johns Hopkins-led and NIH funded OUtMATCH study led to the development of Xolair, a groundbreaking drug that reduces the ...

The U.S. Food and Drug Administration (FDA) says it plans to use artificial intelligence (AI) to help speed the approval of ...